Join Us at ADLM 2026
- Acro Biotech, Inc.
- 5 days ago
- 1 min read
We are delighted to announce our attendance at ADLM 2026, held from July 28 to 30, 2026 at the Anaheim Convention Center, California, USA. We sincerely invite you to visit our booth 1942 to explore our cutting-edge laboratory and diagnostic product portfolio.
ADLM Annual Scientific Meeting & Clinical Lab Expo gathers leading professionals and enterprises across global diagnostic and laboratory sectors, serving as an ideal platform to exchange insights and experience breakthrough technologies reshaping clinical laboratory medicine.
At our booth, ACRO Biotech will showcase our full lineup of newly launched products developed over our decade of R&D efforts. Our exhibition range covers six core categories. First, New DOA Rapid Tests detect multiple substances including Scopolamine, Citalopram, Mirtazapine, Fentanyl and more. Second, Fluorescence Immunoassay Tests detect critical biomarkers such as Troponin I, Prolactin, AMH, HbA1c and Vitamin D. Third, Infectious Disease Rapid Tests cover Malaria, Dengue, Zika, Typhoid, Leishmania and other pathogens.
We will also present our flagship diagnostic instruments: Blood Glucose/Ketone/Uric Acid/Cholesterol Monitoring Meter I, Handheld Fluorescence Immunoassay Analyzer, and AltiSpeed Plus Urine Analyzer. All these products are designed to boost diagnostic precision, streamline testing workflows and support clinical staff to deliver reliable patient testing results.
Our professional technical and sales team will provide on-site product demonstrations and customized consultation. We keep focusing on developing practical testing solutions to address diverse clinical testing demands. Come meet us at booth 1942 to discuss cooperation and discover our latest diagnostic innovations. We are eager to connect with you at ADLM 2026!








Comments